Mass Spectrometry & Applications2026/6/24
Why Do Clinical Laboratories Mainly Use Immunoassays for Macromolecule Testing, While Increasingly Using Mass Spectrometry for Small-Molecule Testing?
In clinical laboratories, macromolecule testing has long been dominated by immunoassays, whereas small-molecule testing is increasingly shifting toward LC-MS/MS. The division of roles between the two types of technologies stems from differences in the analytes themselves: proteins and peptides have multiple epitopes and are well suited to dual-antibody sandwich recognition; small molecules are compact and have many structural analogs, making competitive immunoassays more susceptible to cross-reactivity, and therefore better suited to mass spectrometry platforms that rely on recognition of molecular structural features.
Clinical Mass SpectrometryImmunoassayLC-MS/MSStable Isotope Internal Standards